OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
12.53
-0.09 (-0.71%)
At close: Aug 1, 2025, 4:00 PM
12.43
-0.10 (-0.80%)
After-hours: Aug 1, 2025, 7:54 PM EDT
The Duckhorn Portfolio Market Cap
OptimizeRx has a market cap or net worth of $231.19 million as of August 1, 2025. Its market cap has increased by 20.41% in one year.
Market Cap
231.19M
Enterprise Value
247.42M
1-Year Change
20.41%
Ranking
Category
Stock Price
$12.53
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $231.19M, an increase of 575.99%. That is a compound annual growth rate of 30.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 231.20M | 158.32% |
| Dec 31, 2024 | 89.50M | -65.55% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
| Jun 22, 2018 | 34.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.85B |
| Johnson & Johnson | 400.51B |
| AbbVie | 344.54B |
| AstraZeneca | 232.21B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 222.03B |
| UnitedHealth Group | 217.55B |
| Novo Nordisk | 213.92B |